Translational Insights into the Pathogenesis, Molecular Biomarkers, and Targeted Therapeutics of Endometriosis in Non-Human Primate Models: A Systematic Review

In: Sriwijaya Journal of Obstetrics and Gynecology · 2026 · vol. 4(2) , pp. 56–71 · doi:10.59345/sjog.v4i2.380 · W7225663450
OA: diamond CC0
⚙ AI-generated summary by qwen3.7-flash, 2026-11-15 ⓘ

This systematic review synthesizes evidence from twenty non-human primate studies to evaluate pathogenesis, molecular biomarkers, and targeted therapeutics for endometriosis, highlighting high translational fidelity despite limited study certainty.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-11-14 · read from full text ⓘ

This systematic review evaluated non-human primate models to assess the pathogenesis, biomarkers, and therapeutics of endometriosis. The analysis synthesized twenty studies involving baboons and macaques, identifying that certain drugs like rosiglitazone and letrozole reduced lesion burden while others failed or worsened outcomes. The authors noted that small sample sizes and short study durations limit the certainty of these findings regarding translational fidelity. This paper is centrally about endometriosis — specifically utilizing non-human primate models to understand disease mechanisms and test potential treatments.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Background: Endometriosis is a chronic, estrogen-dependent gynecological dis-order affecting 10–15% of reproductive-aged women worldwide. Unlike rodents, Old World non-human primates (NHPs) menstruate spontaneously and develop lesions that are histologically indistinguishable from human disease. Objective: To evaluate NHP evidence on the pathogenesis, molecular and imaging biomarkers, and targeted therapeutics of endometriosis. Methods: This review followed PRISMA 2020 and Synthesis Without Meta-analysis (SWiM) guidelines. Four databases were searched through July 2026 for original NHP endometriosis studies. Risk of bias (five domains) and certainty (GRADE narrative) were appraised. Results: Of 426 records, 20 studies (N = 299 NHPs: 132 olive baboons, 96 rhe-sus macaques, 55 cynomolgus macaques, and 16 mixed macaques) were synthe-sized in four clusters. In Cluster 1 (k = 5, N = 85), rosiglitazone (−51.8% lesion area), letrozole, the 17β-HSD1 inhibitor PBRM (−67% red lesions), and dienogest reduced lesion burden or central pain sensitization; testosterone with a Western-style diet accelerated Stage III/IV endometrioma. In Cluster 2 (k = 4, N = 61; Low certainty), bentamapimod and rhTNFbp-1 regressed active lesions, anti-TNF-α mAb c5N did not improve fecundity (18% vs. 30% placebo), and intraperitoneal mesenchymal stem cells worsened endometriosis scores (P = 0.02). Cluster 3 (k = 8, N = 109) described collective invasion, mitochondrial depletion, Treg:Th17 dysbiosis, 92.9% induction by intrauterine puncture, and oviductal Anoctamin-1 attenuation. Cluster 4 (k = 3, N = 44) reported serum miRNAs, CXCL13, and PET/CT imaging. Conclusion: NHP models offer high translational fidelity for developing fertility-sparing therapeutics and biomarkers; small, short-term studies limit certainty.
Full text 2,126 characters · extracted from oa-doi-fallback · 6 sections · click to expand

Abstract

Background: Endometriosis is a chronic, estrogen-dependent gynecological dis-order affecting 10–15% of reproductive-aged women worldwide. Unlike rodents, Old World non-human primates (NHPs) menstruate spontaneously and develop lesions that are histologically indistinguishable from human disease.

Objective

To evaluate NHP evidence on the pathogenesis, molecular and imaging biomarkers, and targeted therapeutics of endometriosis.

Methods

This review followed PRISMA 2020 and Synthesis Without Meta-analysis (SWiM) guidelines. Four databases were searched through July 2026 for original NHP endometriosis studies. Risk of bias (five domains) and certainty (GRADE narrative) were appraised.

Results

Of 426 records, 20 studies (N = 299 NHPs: 132 olive baboons, 96 rhe-sus macaques, 55 cynomolgus macaques, and 16 mixed macaques) were synthe-sized in four clusters. In Cluster 1 (k = 5, N = 85), rosiglitazone (−51.8% lesion area), letrozole, the 17β-HSD1 inhibitor PBRM (−67% red lesions), and dienogest reduced lesion burden or central pain sensitization; testosterone with a Western-style diet accelerated Stage III/IV endometrioma. In Cluster 2 (k = 4, N = 61; Low certainty), bentamapimod and rhTNFbp-1 regressed active lesions, anti-TNF-α mAb c5N did not improve fecundity (18% vs. 30% placebo), and intraperitoneal mesenchymal stem cells worsened endometriosis scores (P = 0.02). Cluster 3 (k = 8, N = 109) described collective invasion, mitochondrial depletion, Treg:Th17 dysbiosis, 92.9% induction by intrauterine puncture, and oviductal Anoctamin-1 attenuation. Cluster 4 (k = 3, N = 44) reported serum miRNAs, CXCL13, and PET/CT imaging.

Conclusion

NHP models offer high translational fidelity for developing fertility-sparing therapeutics and biomarkers; small, short-term studies limit certainty.

Keywords

Article Details Sriwijaya Journal of Obstetrics and Gynecology (SJOG) allow the author(s) to hold the copyright without restrictions and allow the author(s) to retain publishing rights without restrictions, also the owner of the commercial rights to the article is the author.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (73)

Source provenance

openalex
last seen: 2026-11-22T06:06:27.128750+00:00
License: CC0 · commercial use OK